Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of in Vivo Lymphodepletion on Outcome in Children with Nonmalignant Disorders Receiving Peripheral Blood Stem Cell Transplantation.
Ottaviano G, Achini-Gutzwiller F, Kalwak K, Lanino E, Faraci M, Rao K, Chiesa R, Amrolia P, Bonanomi S, Rovelli A, Veys P, Lankester A, Balduzzi A, Lucchini G. Ottaviano G, et al. Among authors: chiesa r. Transplant Cell Ther. 2021 Dec;27(12):1020.e1-1020.e5. doi: 10.1016/j.jtct.2021.08.015. Epub 2021 Aug 24. Transplant Cell Ther. 2021. PMID: 34450334 Free article.
Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation.
Worth A, Conyers R, Cohen J, Jagani M, Chiesa R, Rao K, Goulden N, Veys P, Amrolia PJ. Worth A, et al. Among authors: chiesa r. Br J Haematol. 2011 Nov;155(3):377-85. doi: 10.1111/j.1365-2141.2011.08855.x. Epub 2011 Sep 13. Br J Haematol. 2011. PMID: 21910716 Free article.
Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant.
Chiesa R, Gilmour K, Qasim W, Adams S, Worth AJ, Zhan H, Montiel-Equihua CA, Derniame S, Cale C, Rao K, Hiwarkar P, Hough R, Saudemont A, Fahrenkrog CS, Goulden N, Amrolia PJ, Veys P. Chiesa R, et al. Br J Haematol. 2012 Mar;156(5):656-66. doi: 10.1111/j.1365-2141.2011.08994.x. Epub 2012 Jan 9. Br J Haematol. 2012. PMID: 22224700 Free article.
Alternative donor SCT for the treatment of MHC class II deficiency.
Small TN, Qasim W, Friedrich W, Chiesa R, Bleesing JJ, Scurlock A, Veys P, Sparber-Sauer M. Small TN, et al. Among authors: chiesa r. Bone Marrow Transplant. 2013 Feb;48(2):226-32. doi: 10.1038/bmt.2012.140. Epub 2012 Sep 24. Bone Marrow Transplant. 2013. PMID: 23000650
Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients.
Hiwarkar P, Gaspar HB, Gilmour K, Jagani M, Chiesa R, Bennett-Rees N, Breuer J, Rao K, Cale C, Goulden N, Davies G, Amrolia P, Veys P, Qasim W. Hiwarkar P, et al. Among authors: chiesa r. Bone Marrow Transplant. 2013 Jun;48(6):803-8. doi: 10.1038/bmt.2012.221. Epub 2012 Nov 26. Bone Marrow Transplant. 2013. PMID: 23178547
767 results